FindTrial
Sign In

A multicenter, randomized, blinded, positive-phase, parallel-controlled study evaluating the efficacy and safety of atropine sulfate eye drops for refractive error

A multicenter, randomized, blinded, positive-phase, parallel-controlled study evaluating the efficacy and safety of atropine sulfate eye drops for refractive error

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013987
Enrollment
Unknown
Registered
2017-12-16
Start date
2006-09-08
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractive error

Interventions

experiment group:1% Atropine sulfate drop
experiment group:1%Atropine sulfate gel

Sponsors

Eye and ENT Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. less than or equal to 12 years of age, gender is not limited; 2. far or near vision needing ciliary muscle paraplegia optometry; 3. within a month did not use other atropine drugs, either partially or whole body; 4. signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. combined with other eye diseases; 2. allergic to any component of this product; 3. there are other diseases are not suitable for atropine eye drops mydriasis; 4. suffering from other systemic diseases.

Design outcomes

Primary

MeasureTime frame
accommadation ability;puiple diameter;—

Countries

China

Contacts

Public ContactQu Xiaomei

Eye and ENT hospital, Fudan University

quxiaomei2002@126.com+86 13609649279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026